In this study, we built a new model (ARiCa: Asian Risk Calculator) for estimating the likelihood of carrying a pathogenic variant in BRCA1 or BRCA2 gene, using germline BRCA genetic testing results in a cross-sectional population-based study of 8,162 Asian breast cancer patients. This evidence concerns the gene BRCA2 and breast cancer.